
Suriphon Singha/iStock via Getty Images
- Tempus AI (NASDAQ:TEM) said that it has obtained 510((k)) clearance from the U.S. FDA for Tempus ECG-Low EF software.
- This software utilizes artificial intelligence to help identify patients who may be experiencing a low left ventricular ejection fraction, a measure of